Driving biotech companies to do more with their data | Revealing strategic insights for the life sciences industry
While attending the #ProcessDevelopment for #CellTherapies Summit this week, I've heard the need to move fast in this tight funding environment. If you can't move fast, your life saving therapeutic won't make it to market. What prevents companies from moving fast? It depends... - Difficulty maintaining potency with high yield - Scaling up challenges - Cryopreservation hurdles - Difficulty during tech transfer to CDMOs - Selecting & maintaining starting material quality What lies behind all of these challenges? A lack of easily accessible data. With a connected, automated lab, scientists can make decisions more quickly, scale processes with ease, and can pull together a tech transfer package within days instead of months. Want to learn how? Reach out to our team at ZAETHER
